USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	038249/0590			Pages:	7
		Recorded:	03/24/2016
Attorney Dkt #:	33677.99999
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 13

Patent #:	5298019	Issue Dt:	03/29/1994	Application #:	08004090	Filing Dt:	01/13/1993
Title:	CONTROLLED ADMINISTRATION OF CHEMODENERVATING PHARMACEUTICALS

Patent #:	NONE	Issue Dt:		Application #:	10212657	Filing Dt:	08/05/2002
Publication #:	US20020187164	Pub Dt:	12/12/2002
Title:	Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases

Patent #:	7270826	Issue Dt:	09/18/2007	Application #:	11028600	Filing Dt:	01/05/2005
Publication #:	US20050208075	Pub Dt:	09/22/2005
Title:	METHODS OF USING BOTULINUM TOXIN FOR THE TREATMENT OF HYPERVOLEMIC LIP DEFORMITY (LIP ECTROPION)

Patent #:	7943152	Issue Dt:	05/17/2011	Application #:	12010183	Filing Dt:	01/22/2008
Publication #:	US20080118533	Pub Dt:	05/22/2008
Title:	TREATMENT OF CHRONIC CHALAZION AND HORDEOLUM WITH BOTULINUM TOXIN

Patent #:	8679486	Issue Dt:	03/25/2014	Application #:	12662186	Filing Dt:	04/05/2010
Publication #:	US20100279945	Pub Dt:	11/04/2010
Title:	HIGH-POTENCY BOTULINUM TOXIN FORMULATIONS

Patent #:	NONE	Issue Dt:		Application #:	14225011	Filing Dt:	03/25/2014
Publication #:	US20140315820	Pub Dt:	10/23/2014
Title:	High-Potency Botulinum Toxin Formulations

Patent #:	NONE	Issue Dt:		Application #:	14464740	Filing Dt:	08/21/2014
Publication #:	US20170319667	Pub Dt:	11/09/2017
Title:	Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Patent #:	NONE	Issue Dt:		Application #:	14555870	Filing Dt:	11/28/2014
Publication #:	US20150086533	Pub Dt:	03/26/2015
Title:	Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Patent #:	NONE	Issue Dt:		Application #:	14573659	Filing Dt:	12/17/2014
Publication #:	US20170143807	Pub Dt:	05/25/2017
Title:	Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Patent #:	NONE	Issue Dt:		Application #:	14753917	Filing Dt:	06/29/2015
Publication #:	US20150297688	Pub Dt:	10/22/2015
Title:	Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Patent #:	9950042	Issue Dt:	04/24/2018	Application #:	14754268	Filing Dt:	06/29/2015
Publication #:	US20150297684	Pub Dt:	10/22/2015
Title:	Extended Length Botulinum Toxin Formulation for Human or Mammalian Use

Patent #:	9901627	Issue Dt:	02/27/2018	Application #:	14803574	Filing Dt:	07/20/2015
Publication #:	US20160015794	Pub Dt:	01/21/2016
Title:	Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease

Patent #:	10441641	Issue Dt:	10/15/2019	Application #:	14852990	Filing Dt:	09/14/2015
Publication #:	US20170252415	Pub Dt:	09/07/2017
Title:	Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Assignor

Exec Dt:

03/23/2016

Assignee

1261 FURNACE BROOK PARKWAY

QUINCY, MASSACHUSETTS 02169

Correspondence name and address
	MILBANK, TWEED, HADLEY AND MCCLOY LLP
	1850 K STREET NW
	SUITE 1100
	WASHINGTON, DC 20006

Search Results as of: 07/11/2025 10:03 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6